Blocking Fragment of CDCP1

Triple-negative breast cancer (TNBC) refers to any breast cancer that does not express the genes for estrogen receptor (ER), progesterone receptor (PR) or Her2/neu. TNBC is difficult to treat since most hormone therapies target one of these receptors. Researchers at UCI have developed a therapeutic that bypasses these receptors, and instead targets fatty acid oxidation, a process linked to TNBC. Maria Tkachuk mtkachuk@uci.edu 949-824-2288

January 17, 2018

Related Blog

Smart, interactive desk

May 8, 2023 No Comments

Get ready to take your space management game to the next level with the University of Glasgow’s innovative project! By combining the

Ultra-Cooled Autonomous Container (UAC) for the Transport and Storage of Goods

December 23, 2022 No Comments

Universitat Politècnica de València Background The current health emergency context has challenged technology in various industrial sectors. In particular, the recent manufacture

Mechanical Hamstring™

December 22, 2022 No Comments

University of Delaware Technology Overview This device was created to allow athletes who suffer a hamstring strain to return to the field

Blocking Fragment of CDCP1

Related Blog

Smart, interactive desk

Ultra-Cooled Autonomous Container (UAC) for the Transport and Storage of Goods

Mechanical Hamstring™

Join Our Newsletter